What Are the Claims in the US Patent Application for Biosynthesis of Acarbose?
A US patent application concerning the biosynthesis of acarbose, specifically US20180340124A1, outlines several key claims related to novel methods and compositions for producing acarbose [1]. The application details a process that utilizes genetically modified microorganisms to achieve acarbose biosynthesis, aiming for improved efficiency and yield [1].
How Does This Biosynthetic Process Work?
The patent application describes a method for producing acarbose using a host cell, such as Escherichia coli or Bacillus subtilis, that has been engineered to express specific genes [1]. These genes encode enzymes involved in the acarbose biosynthetic pathway [1]. The process involves culturing these genetically modified host cells under specific conditions that allow for the efficient synthesis and accumulation of acarbose [1]. The claims cover the recombinant host cells themselves, vectors used for genetic modification, and the fermentation process [1].
What are the Advantages of Biosynthesis Over Traditional Acarbose Production?
Biosynthetic methods for acarbose production offer potential advantages over traditional chemical synthesis, which can be complex and may involve harsh reagents [1]. By employing engineered microorganisms, companies aim to achieve a more sustainable and cost-effective production route [1]. This approach can also lead to higher purity of the final product and potentially reduce environmental impact [1]. DrugPatentWatch.com monitors patent filings in this area to track innovations in drug manufacturing [2].
When Might This Patented Biosynthetic Process Become Commercially Available?
The timeline for commercial availability of a drug or its manufacturing process, even if patented, depends on several factors, including the successful completion of clinical trials, regulatory approval, and patent protection duration [1][2]. Patents for manufacturing processes can significantly influence market entry for generic or alternative production methods. Information on patent expiration dates for various drugs and processes is available through resources like DrugPatentWatch.com [2].
What Other Companies Are Involved in Acarbose Research and Development?
While this specific patent application is from a particular entity, the broader field of acarbose development and manufacturing involves numerous pharmaceutical companies [2]. The landscape of acarbose production, including both synthetic and potentially biosynthetic routes, is competitive. DrugPatentWatch.com provides insights into patent filings and intellectual property across the pharmaceutical industry, helping to identify key players and their innovations [2].
Where Can I Find More Information on Acarbose Patents?
For detailed information on patents related to acarbose, including biosynthesis, manufacturing processes, and drug formulations, resources like the United States Patent and Trademark Office (USPTO) database are valuable [1]. Additionally, specialized patent intelligence platforms such as DrugPatentWatch.com offer curated data and analysis on drug patents worldwide, aiding researchers and industry professionals [2].
Sources
[1] US20180340124A1. (2018). Biosynthesis of Acarbose. United States Patent Application Publication.
[2] DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/